Correlation Between Co Diagnostics and Novavax

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Co Diagnostics and Novavax at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Co Diagnostics and Novavax into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Co Diagnostics and Novavax, you can compare the effects of market volatilities on Co Diagnostics and Novavax and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Co Diagnostics with a short position of Novavax. Check out your portfolio center. Please also check ongoing floating volatility patterns of Co Diagnostics and Novavax.

Diversification Opportunities for Co Diagnostics and Novavax

-0.23
  Correlation Coefficient

Very good diversification

The 3 months correlation between CODX and Novavax is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Co Diagnostics and Novavax in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novavax and Co Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Co Diagnostics are associated (or correlated) with Novavax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novavax has no effect on the direction of Co Diagnostics i.e., Co Diagnostics and Novavax go up and down completely randomly.

Pair Corralation between Co Diagnostics and Novavax

Given the investment horizon of 90 days Co Diagnostics is expected to generate 3.59 times less return on investment than Novavax. In addition to that, Co Diagnostics is 1.18 times more volatile than Novavax. It trades about 0.02 of its total potential returns per unit of risk. Novavax is currently generating about 0.1 per unit of volatility. If you would invest  774.00  in Novavax on May 19, 2025 and sell it today you would earn a total of  184.00  from holding Novavax or generate 23.77% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Co Diagnostics  vs.  Novavax

 Performance 
       Timeline  
Co Diagnostics 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Co Diagnostics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating fundamental indicators, Co Diagnostics may actually be approaching a critical reversion point that can send shares even higher in September 2025.
Novavax 

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Novavax are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Novavax showed solid returns over the last few months and may actually be approaching a breakup point.

Co Diagnostics and Novavax Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Co Diagnostics and Novavax

The main advantage of trading using opposite Co Diagnostics and Novavax positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Co Diagnostics position performs unexpectedly, Novavax can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novavax will offset losses from the drop in Novavax's long position.
The idea behind Co Diagnostics and Novavax pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Money Managers
Screen money managers from public funds and ETFs managed around the world
Stocks Directory
Find actively traded stocks across global markets